HOME >> BIOLOGY >> NEWS
New target for HIV/AIDS drugs and vaccine discovered

Researchers from Rome, Italy, describe a finding in the August 2007 print issue of The FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection. It has been known that HIV proteins disable the antibody-forming part of the immune system (the homeland defense or acquired immune system). In this report, researchers demonstrate for the first time how the HIV-1 Nef viral protein delivers a one-two punch to the bodys innate immune system (our early warning system composed of dendritic and natural killer cells). First, Nef hijacks dendritic cells (DCs) to upset the function of natural killer (NK) cells. Second, after blocking this first line of defense against the immune system, Nef uses DCs and NK cells to create a microenvironment that actually makes it easier for HIV/AIDS to replicate.

According to Maria Giovanna Quaranta of Instituto Superiore de Sanit and first author of the article, The findings described in this work may have several implications for AIDS treatment: the understanding of Nef function, mechanism of action, and cellular partners might aid the discovery of suitable drugs able to block the activity of this smart protein. Quaranta added, An exciting possibility is the design of a vaccine including a mutated Nef protein unable to assist the virus in the control of its host.

The research findings also raise another intriguing possibility: Nef proteins may be able to boost or suppress DC and NK cell activity. If so, it may prove to be a valuable new therapeutic approach for people with diseases and disorders that involve overactive or underactive immune responses. DCs and NK cells play critical roles in the bodys initial defense against infection. DCs are instrumental in identifying foreign invaders to the body and then orchestrating an immune response that ultimately removes them. NK cells are among the first cells summoned by DCs to help isolate and contain the infection un
'"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
26-Jul-2007


Page: 1 2

Related biology news :

1. Huntingtons disease study shows animal models on target
2. When off-target is right on
3. Genomic analysis uncovers new targets for HIV vaccine
4. Bulls-eye -- Programs targeting math, science teacher shortage may get boost
5. Scientists take next step in understanding potential target for ovarian cancer treatment
6. On target
7. New way to target and kill antibiotic-resistant bacteria found
8. Weill Cornell team identifies potential new cancer drug target
9. CSHL scientists successfully target tumor microenvironment to stop cancer growth
10. Sleep deprivation affects airport baggage screeners ability to detect rare targets
11. Genomic signatures identify targeted therapies for lung cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... ... January 23, 2020 , ... Asymmetrex ... Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampshire, ARMI is the ... partner organizations from industry, government, academia and the non-profit sector to develop ...
(Date:1/10/2020)... ... January 09, 2020 , ... Cutting Edge Spine, a ... 510(K) clearance and commercial launch of the latest addition to its bioactive portfolio ... EVOL®ha-DLIF is made of PEEK-OPTIMA HA Enhanced material supplied by Invibio Biomaterial Solutions. ...
(Date:1/2/2020)... Texas (PRWEB) , ... January 02, 2020 , ... ... custom and semi-custom aqueous reagents, chemicals, and medias, as well as medical grade ... and cell- and tissue-based product manufacturers. , “We are excited to bring ...
Breaking Biology News(10 mins):
(Date:12/31/2019)... ... December 31, 2019 , ... ... product development lab in Maryland. Emphasis will be in expanding capabilities ... capabilities, Vici Health Sciences will be well positioned to meet the growing demand ...
(Date:12/27/2019)... ... December 27, 2019 , ... Leak Detection ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited to ... Following acquisition by CLJ Holdings in February, 2019, a comprehensive and aggressive reorganization ...
(Date:12/18/2019)... Ariz. (PRWEB) , ... December 17, 2019 , ... ... has received its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the ... closest competitors, Stryker Sustainability Solutions and SterilMed (a Johnson & Johnson company) have ...
(Date:12/14/2019)... ... December 12, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... The new LDA LT80 (LOW TEMPERATURE -80C) helium leak testing system is designed ...
Breaking Biology Technology:
Cached News: